KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oracle (ORCL) Exchange Rate Effect (2016 - 2026)

Oracle (ORCL) has disclosed Exchange Rate Effect for 18 consecutive years, with $109.0 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Exchange Rate Effect rose 313.73% year-over-year to $109.0 million, compared with a TTM value of $312.0 million through Feb 2026, up 291.41%, and an annual FY2025 reading of $124.0 million, up 277.14% over the prior year.
  • Exchange Rate Effect was $109.0 million for Q1 2026 at Oracle, up from -$43.0 million in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $219.0 million in Q2 2025 and bottomed at -$203.0 million in Q3 2022.
  • Average Exchange Rate Effect over 5 years is -$6.6 million, with a median of $8.0 million recorded in 2024.
  • Peak annual rise in Exchange Rate Effect hit 422.06% in 2025, while the deepest fall reached 737.5% in 2025.
  • Year by year, Exchange Rate Effect stood at $29.0 million in 2022, then dropped by 10.34% to $26.0 million in 2023, then tumbled by 596.15% to -$129.0 million in 2024, then surged by 66.67% to -$43.0 million in 2025, then surged by 353.49% to $109.0 million in 2026.
  • Business Quant data shows Exchange Rate Effect for ORCL at $109.0 million in Q1 2026, -$43.0 million in Q4 2025, and $27.0 million in Q3 2025.